Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
29 01 2023
Historique:
received: 22 12 2022
revised: 26 01 2023
accepted: 28 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

This research examines whether the Coronavirus disease 2019 (COVID-19) did harm to the population's health through comparing the changes in the life expectancy of Canadians with those of Australians over the period from March 2019 to February 2021 by using a difference-in-differences (DID) estimation method. We found that the pandemic did cause differences in life expectancies between Canada and Australia, probably because of different initial control policies for COVID-19. This study uses the indicator of disability-adjusted life years (DALYs) to measure the societal health burden, which was corroborated by estimating temporal productivity loss (TPL) and permanent productivity loss (PPL) based on the human capital approach (HCA) using data from Health Canada. The societal health burden in Canada amounted to 6.493 DALYs per 1000 male persons and 5.316 DALYs per 1000 female persons. The economy's permanent productivity loss was around USD 5.3 billion, while the temporary productivity loss was around USD 3 billion from February 2020 to April 2022. The sum of the above two losses amounted to 0.477% of the GDP in 2019. Swift and decisive decisions at the very early stage of a pandemic can nip contagions in the bud before numbers get out of hand and would be less damaging to people's health and the economy, as seen in Australia, in contrast to what happened in Canada. We thus recommend that such policies plus telecommunication systems in healthcare services be implemented early on to cope with the future outbreak of any emerging infectious diseases such as COVID-19.

Identifiants

pubmed: 36767785
pii: ijerph20032419
doi: 10.3390/ijerph20032419
pmc: PMC9916087
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Eur J Pharmacol. 2020 Nov 5;886:173457
pubmed: 32750366
Sci Rep. 2020 Nov 3;10(1):18909
pubmed: 33144595
Nature. 2020 Jun;582(7812):389-394
pubmed: 32349120
Nat Hum Behav. 2022 Dec;6(12):1649-1659
pubmed: 36253520
Lancet. 2020 Mar 14;395(10227):846-848
pubmed: 32151325
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):
pubmed: 33446511
J Health Econ. 2015 May;41:46-58
pubmed: 25666229
Int J Environ Res Public Health. 2020 Jun 13;17(12):
pubmed: 32545827
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Popul Health Metr. 2014 Aug 23;12:20
pubmed: 26019690
J Med Econ. 2019 Jun;22(6):501-508
pubmed: 30384792
Arch Public Health. 2022 Mar 24;80(1):91
pubmed: 35331325
Soc Sci Med. 2007 Apr;64(8):1665-78
pubmed: 17250940
J King Saud Univ Sci. 2021 Mar;33(2):101348
pubmed: 35495615
Ann Epidemiol. 2021 Nov;63:63-67
pubmed: 34314847
JACC Case Rep. 2020 Jul 15;2(9):1407-1410
pubmed: 32373791
Int J Environ Res Public Health. 2022 Jan 17;19(2):
pubmed: 35055834
J Public Econ. 2021 Jan;193:104311
pubmed: 33262548

Auteurs

Fuhmei Wang (F)

Department of Economics, College of Social Science, National Cheng Kung University, Tainan 704, Taiwan.
Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

Jinwei Lui (J)

Department of Economics, College of Social Science, National Cheng Kung University, Tainan 704, Taiwan.

Jung-Der Wang (JD)

Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Department of Occupational and Environmental Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH